Due to the current molybdenum-99 shortage, EviCore medical reviewers are following appropriate use criteria regarding appropriate alternative imaging studies. Please follow the link below to access the EviCore statement regarding this issue.
If the EviCore login frame is missing for you, please refresh the web page with Ctrl+F5 or click here to log in.
EviCore by Evernorth leverages our clinical expertise, evidence-based guidelines, and innovative technologies to deliver best-in-class medical benefit management solutions that inform more effective, affordable treatment and site of care decisions for each patient’s needs. The result: Better outcomes and lower costs for patients, providers, and plans.
There are over 100 different types of known cancers, and out of those, three types are the most common in men and women. We've compiled information on symptoms, helpful tips, and stats on clinical trials on the most common types of cancer.
Mary* is a 60-year-old patient who has been experiencing balance issues. She has fallen several times. Her doctor identifies an abnormal walking pattern. Learn more and click through Mary's journey.
Today’s complex, fragmented health care system doesn’t always meet individual care needs. It can also be burdensome for providers and often costs more than it should.
EviCore by Evernorth® is working to continuously improve the utilization management solutions we offer today and transform the solutions we’ll offer tomorrow. Reducing the administrative burden for providers is a major focus of our efforts with intelliPath.
There may not be a more misunderstood part of the health care system than utilization management (UM). UM helps ensure that members receive health care services that are appropriate, necessary, and cost-effective.
With more than 30 years of excellence, EviCore is specifically designed to address the complexities of our health care system today and tomorrow. We partner with plans and providers nationwide to improve care and affordability for more than 100 million patients.
